|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01102205 |
|
Date of registration:
|
09/04/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease
|
|
Scientific title:
|
Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease |
|
Date of first enrolment:
|
April 2010 |
|
Target sample size:
|
130 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01102205 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
Mehmet ali Cikrikcioglu, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
vakif gureba TRH,fatih,istanbul,turkey.specialist in internal medicine |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age more than 18 years
Exclusion Criteria:
- inability to give a written consent
- other conditions and drug usage affect oxidative stress
Age minimum:
18 Years
Age maximum:
95 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hashimoto Disease
|
|
Primary Outcome(s)
|
|
Poxidative stress markers
[Time Frame: After levotren therapy]
|
|
Secondary ID(s)
|
|
tastoshashi
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|